Atlas Trials

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Clinical trial NCT04711135 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04711135
Sponsor
Advanced Accelerator Applications
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Start date
2022-08-31
Primary completion
2024-03-12
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.